Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM StudyLudwig Kappos, Till Sprenger, Carlo Pozzilli et al.|JAMA Neurology|2021Cited by 218
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo et al.|Neurology|2016Cited by 135
Switching from natalizumab to fingolimodLudwig Kappos, Athanasios P. Kyritsis, Ernst‐Wilhelm Radue et al.|Neurology|2015Cited by 116
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease durationHugh Kearney, Declan Chard, Maria A. Rocca et al.|Multiple Sclerosis Journal|2013Cited by 111
The role of the cerebellum in multiple sclerosis—150 years after CharcotKatrin Parmar, Till Sprenger, Christine Stadelmann et al.|Neuroscience & Biobehavioral Reviews|2018Cited by 75